These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 23869492

  • 1. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
    He YM, Feng L, Huo DM, Yang ZH, Liao YH.
    Nephrology (Carlton); 2013 Sep; 18(9):605-14. PubMed ID: 23869492
    [Abstract] [Full Text] [Related]

  • 2. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 3. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R.
    N Engl J Med; 2009 Jul 02; 361(1):40-51. PubMed ID: 19571282
    [Abstract] [Full Text] [Related]

  • 4. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M, Tylicki L, Rutkowski P, Rutkowski B.
    Scand J Urol Nephrol; 2004 Jul 02; 38(5):427-33. PubMed ID: 15764256
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
    Reyes-Marín FA, Calzada C, Ballesteros A, Amato D.
    Rev Invest Clin; 2012 Jul 02; 64(4):315-21. PubMed ID: 23227581
    [Abstract] [Full Text] [Related]

  • 6. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May 02; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 7. [Prescription of renin-angiotensin-aldosterone system blockers in patients with stage 3 chronic kidney disease].
    Alvarez M, Ardiles L.
    Rev Med Chil; 2019 Feb 02; 147(2):173-180. PubMed ID: 31095165
    [Abstract] [Full Text] [Related]

  • 8. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M, Uchida S, Kawamura T, Kuwahara M, Nangaku M, Iino Y, PROTECT-CKD Study Group.
    Clin Exp Nephrol; 2015 Oct 02; 19(5):925-32. PubMed ID: 25680887
    [Abstract] [Full Text] [Related]

  • 9. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
    Schmidt A, Gruber U, Böhmig G, Köller E, Mayer G.
    Nephrol Dial Transplant; 2001 May 02; 16(5):1034-7. PubMed ID: 11328912
    [Abstract] [Full Text] [Related]

  • 10. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.
    Kidney Int; 2009 Nov 02; 76(9):960-7. PubMed ID: 19625993
    [Abstract] [Full Text] [Related]

  • 11. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Nov 02; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 12. Cough induced by losartan with resolution after substitution with enalapril.
    Dashti-Khavidaki S, Faghihi T, Ahmadi F, Khalili H.
    Clin Ther; 2008 Mar 02; 30(3):548-51. PubMed ID: 18405793
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 02; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 14. Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
    Juhlin T, Erhardt LR, Ottosson H, Jönsson BA, Höglund P.
    Eur J Heart Fail; 2007 Feb 02; 9(2):191-6. PubMed ID: 16859993
    [Abstract] [Full Text] [Related]

  • 15. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
    Caletti MG, Balestracci A, Missoni M, Vezzani C.
    Pediatr Nephrol; 2013 May 02; 28(5):745-50. PubMed ID: 23250713
    [Abstract] [Full Text] [Related]

  • 16. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr 02; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 17. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
    Fraune C, Lange S, Krebs C, Hölzel A, Baucke J, Divac N, Schwedhelm E, Streichert T, Velden J, Garrelds IM, Danser AH, Frenay AR, van Goor H, Jankowski V, Stahl R, Nguyen G, Wenzel UO.
    Am J Physiol Renal Physiol; 2012 Oct 02; 303(7):F1037-48. PubMed ID: 22791343
    [Abstract] [Full Text] [Related]

  • 18. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
    Kiss K, Fekete V, Pálóczi J, Sárközy M, Murlasits Z, Pipis J, Kheyfets IA, Dugina JL, Sergeeva SA, Epstein OI, Csonka C, Csont T, Ferdinandy P, Bencsik P.
    Altern Ther Health Med; 2016 Oct 02; 22(2):10-7. PubMed ID: 27036051
    [Abstract] [Full Text] [Related]

  • 19. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
    Sakallı H, Baskın E, Bayrakcı US, Moray G, Haberal M.
    Exp Clin Transplant; 2014 Aug 02; 12(4):310-3. PubMed ID: 24447308
    [Abstract] [Full Text] [Related]

  • 20. Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease.
    Wu PC, Wu CJ, Lin CJ, Pan CF, Chen CY, Huang TM, Wu CH, Lin SL, Chen YM, Chen L, Wu VC, NSARF Group, Kidney Consortium.
    Clin Pharmacol Ther; 2015 Oct 02; 98(4):442-9. PubMed ID: 26082272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.